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 Cancer is a disease that affects millions around the globe. Treatments such as radiation 
and chemotherapy are often used to treat cancerous tumors, but are not 100% effective in curing 
the patient. Alternatively, some research groups have proposed the use of metallointercalators, 
metal complexes consisting of a rhodium, ruthenium, or iridium metal center with bidentate 
supporting ligands such as bipyridine and phenanthroline, or tridentate ligands such as 
terpyridine. The complexes also contain a bidentate intercalating group such as 
dipyridophenazine. These complexes possess the ability to directly bind to DNA through 
intercalation between the stacks of DNA base pairs, giving them the potential to be used as 
probes to analyze and identify chemically damaged DNA. The ultimate goal would be to design 
molecules that could detect damaged DNA at the molecular level and allow treatment before 
tumors could develop. Our objective is to design and synthesize novel metallointercalator 
complexes of rhenium, and to examine their physical and spectroscopic properties. Specifically, 
we are attempting to prepare [Re(Py2NO)(dppz)L]3+, where L = H2O or NH3. (Py2NO = 4,4-
dimethyl-2,2-di(2-pyridyl)oxazolidine; dpk-OEt = (py)2C(O)OCH2CH3; dppz = 
dipyridophenazine). Reaction of TBA2[Re2Cl8] with the nitroxide ligand Py2NO in acetonitrile 
produces a red/brown compound proposed to be Re(Py2NO)Cl3. Isolation and purification of this 
compound has proven to be a challenge. NMR studies indicate the compound is present as an 
intractable mixture. When the same reaction is performed in ethanol, the blue complex ReO(dpk-
OEt)Cl2 is obtained. The same compound can be isolated in good yield by direct reaction of two 
equivalents of di-2-pyridyl ketone with TBA2[Re2Cl8]. The blue complex has been reacted with 
two equivalents of Ag+ followed by the addition of dppz to produce a brown solid believed to be 
the metallointercalator [ReO(dpk-OEt)dppz]2+. Details of the synthesis along with IR, NMR, and 




 Deoxyribonucleic acid (DNA) is the molecule responsible for holding all of the genetic 
information of every cell in every living organism on the planet. DNA is a polymer which can 
come in various lengths, depending on the amount of information required to facilitate the proper 
function of a cell. This information is stored in the form of four primary bases: Adenine (A), 
Thymine (T), Cytosine (C), and Guanine (G). In a structure of DNA (Fig. 1), these bases are 
found in pairs: A pairs with T, and C pairs with G. The pairs are held together by weak  
 
interactions known as hydrogen bonds, which become extremely strong when combined in a 
group, similar to a bundle of twigs.1 This stacking nature of DNA bases allows for DNA’s well-
known double-helix structure, which is maintained by the bases attaching to a negatively charged 
sugar-phosphate backbone.2 
 DNA bases repeat in various orders throughout a molecule or sequence of DNA. The 
order in which these bases appear in a sequence encodes the genetic information held in a cell. 
The DNA can then be read by other molecules within a cell, and translated into what the base 
sequences code for: proteins. In other words, the order of bases in a DNA sequence dictates how 
Figure 1: Molecular structure of A-T and C-G DNA base pairs. 
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a specific protein is to be constructed. This properly constructed protein can then carry out a task 
which helps to keep the cell functioning properly.2  
 Since DNA codes for proteins, which have an overwhelming diversity of structure and 
function within cells and organisms, it is extremely important to ensure the DNA sequences that 
code for these proteins remain the same. If even one base is altered or mutated, the structure and 
function of the sequence’s corresponding protein can be affected.2 Some of the consequences of 
this can include a protein whose creation was terminated prematurely, or a protein containing the 
wrong amino acids. Both of these scenarios can prevent the protein from functioning properly in 
the cell, because it does not have the proper structure to carry out its function. This lack of 
function can in turn lead to diseases such as cancer.3 
 Over time, an organism’s DNA can accumulate multiple mutations as well as chemical 
modifications. These can result in proteins being formed improperly, as the genetic information 
that codes for the protein is either mutated or disrupted due to DNA damage. Thus, proteins may 
not function properly due to their improper structure, which can have catastrophic consequences 
for both a cell and an organism. 
 Fortunately, the human body has a mechanism to solve the problem of DNA mismatches: 
mismatch repair (MMR) machinery. The DNA mismatch repair machinery consists of enzymes 
that recognize and repair DNA mismatches, reducing their frequency by a factor of 1000.4–6 As 
with other aspects in the genome, however, there can be mutations in the MMR genes, known as 
MMR deficiencies. MMR deficiencies increase the amount of unchecked DNA mutations, which 
can result in an increased risk for developing cancers.6 To add insult to injury, it has been shown 
that MMR deficiencies are associated with an increased tolerance to traditional 
chemotherapeutics such as cisplatin, carboplatin, doxorubicin, and mercaptopurine.5,7 MMR 
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deficiencies are therefore a high-priority target for cancer recognition treatment. There are other 
mechanisms in cells to repair DNA damage, known as lesions, which work similarly to the 
mismatch repair machinery. Like MMR deficiencies, deficiencies in the DNA lesion repair genes 
can lead to increased DNA damage in cells, and thus a higher risk for developing cancer. 
 One proposed treatment solution to cancer and other genetic disorders is DNA repair. 
Disorders such as cancers, Huntington’s disease, cystic fibrosis, sickle cell anemia, and even 
Alzheimer’s and Parkinson’s diseases have been linked to missing, mismatched, or chemically 
damaged DNA.3 The way to treat these diseases would be to treat them at the smallest level 
possible: repairing or replacing the damaged or missing DNA sequence to reflect the complete, 
undamaged sequence. Consequently, the cell would now be able to properly carry out its 
function by synthesizing the complete protein required to carry out the function that the cell was 
previously unable to do. Repairing MMR deficiencies would be advantageous as well, as the cell 
would then be able to perform gene repair without outside assistance. 
 In order to repair damaged DNA, it must be found. Thus, molecules that can selectively 
recognize and bind to DNA would be highly valuable. One such class of molecules, known as 
metallointercalators, has been shown to act as a DNA probe with some success. A 
metallointercalator, as shown by Figure 2, is a metal complex which contains a metal center, one 
or more supporting ligands, and an intercalating group.  
Figure 2: Diagram of a general metallointercalator complex, showing the metal ion, 
supporting group, and intercalating group. 
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 The binding mode of a metallointercalator complex to DNA consists of three 
components, which work in concert: the first, and typically strongest, binding component is an 
electrostatic interaction between the positively-charged metal complex and the negatively-
charged sugar-phosphate backbone of DNA. The second component consists of aromatic pi-
stacking interactions between the aromatic, hydrophobic intercalating group and the aromatic 
DNA base pairs. Finally, hydrogen bond interactions can take place between the capping ligand 
or ancillary groups on the metallointercalator complex and the hydrogen bond donors and 
acceptors on the sugar-phosphate backbone of DNA. This provides added stability for the 
complex when bound to DNA, and can be used to recognize specific base pair sequences. 
 The metal ion is the centerpiece of the metallointercalator complex. Acting as a 
foundation, the metal center is the site to which the supporting ligand, intercalating group, and 
ancillary groups coordinate. The metal center also provides the complex with a net positive 
charge. A more positively-charged metal center allows for a stronger electrostatic interaction 
between the positively-charged metallointercalator and the negatively-charged DNA backbone. 
The most extensively used metal centers for these complexes have traditionally been RhIII and 
RuII/III.8 These metals possess low spin d5 and d6 configurations which renders them inert with 




 The intercalating group is the ligand which inserts between the DNA base pairs, similar 
to sliding between the rungs of a ladder. Intercalating groups are planar, hydrophobic, aromatic, 
organic compounds consisting of three to five or more rings. Most intercalating groups are 
bidentate, coordinating to the metal center through two nitrogen atoms. Common examples are 
dipyridophenazine (dppz),  a conjugated five-ring system containing four nitrogen atoms, two of 
which coordinate to the metal center, as well as phi, a conjugated three-ring system that 
coordinates to the metal center through two nitrogen atoms (Fig. 2). Figure 3 shows the possible 
variation in polypyridyl intercalating groups like dppz, highlighting the ability to adjust the 
length of the intercalator. When bound to DNA, intercalating groups exhibit both hydrophobic 
and pi-stacking interactions with the DNA base pairs, contributing to the stability of the 
metallointercalator-DNA complex as a whole. 
 One important property of several metallointercalator complexes is their ability to emit 
light upon intercalation, otherwise known as “light-switch complexes”. One such complex is 
Figure 3: Diagram of an iridium metallointercalator complex highlighting the possible 
variation in polypyridyl intercalating groups. Bipyridine, phenanthroline, dpq, dppz, and 
dppn are shown.21 
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[Ru(bpy)2(dppz)]2+ (bpy = bipyridine), shown in Figure 4. This metal complex does not fluoresce 
when by itself in aqueous solution, but when bound to DNA, the complex emits red light.9 This 
is due to water hydrogen bonding to the nitrogen atoms of dppz when in solution, preventing the 
emission of light. When interacting with DNA, however, dppz is intercalated between the base 
pairs in the hydrophobic region of DNA. Thus, water is unable to hydrogen bond with dppz’s 
nitrogen atoms, allowing for light emission.9 This unique property has the potential to be applied 
to other metallointercalator complexes, possibly allowing for differing  
fluorescent properties based on the substituent and supporting groups bound to the metal ion 
center.  
 Many of the known light-switch complexes are Ru-dppz based intercalators. Another 
intercalator variation, based on Rh-phi, has demonstrated the ability to cleave DNA strands when 
exposed to UV light in the 313-325 nm range.10,11 Two examples of these photocleaving 











been discovered that the shape of these complexes dictates their method of DNA recognition and 
cleavage. In other words,  the shape of each complex, or the way it is designed, changes how the 
complex recognizes, binds to, and cleaves the DNA strand.11 
 Although extensive work has been conducted in the synthesis and characterization of 
rhodium and ruthenium metallointercalators, rhenium-based metallointercalator complexes are 
largely unknown. To date, there has been one known report of a ReI-dppz complex used as a 
metallointercalator12: [Re(CO)3(4-MePy)dppz]+ (4-MePy = 4-methylpyridine), shown by Figure 
Figure 6: Chemical structure of the first reported rhenium-based metallointercalator 
complex: [Re(CO)3(4-MePy)dppz]+.12 
Figure 5: Chemical structures of two Rh-phi metallointercalator complexes, 
[Ru(phen)2(phi)]3+ and [Rh(phi)2(bpy)]3+, with the ability to photocleave DNA. The mode of 




6. This complex was shown to intercalate into DNA, and like the RuII complexes previously 
mentioned, the complex exhibited fluorescence upon intercalation.12 It has also been found that 
ReI intercalators possess the ability to photocleave DNA.13 
 Further research was conducted with essentially the same complex, [Re(CO)3(Py)dppz]+, 
where 4-methylpyridine was substituted with pyridine (Py). During their research into amyloid 
beta peptide aggregation and its affects in Alzheimer’s disease, Martí et al. discovered that 
[Re(CO)3(Py)dppz]+ also exhibits fluorescence in the presence of amyloid beta, in addition to 
DNA.14 
 Some research groups have worked with metalloinsertors, rather than 
metallointercalators, and it is important to highlight this distinction. A metallointercalator is a 
complex whose planar substituent group intercalates into, or inserts between, DNA base pairs. 
The DNA must stretch (which increases its viscosity) in order to accommodate the intercalating 
substituent of the metal complex, however the DNA strand remains intact.8,15 Conversely, 
metalloinsertors interact with DNA in a way that results in the ejection of one or more bases 
from a strand of DNA.10 This can be advantageous, as Barton et al. discuss the ability of the 
metalloinsertor [Rh(bpy)2(chrysi)]3+ to eject DNA mismatches, resulting in recognizable DNA 
lesions which have been shown to cause selective cell death of MMR-deficient cells, but not 
MMR-proficient cells.15 
 Despite their differences, parallels can be drawn between metallointercalators and 
metalloinsertors, and lessons can be learned in the design and application of metallointercalators. 
Barton et al. reported in 2011 that rhodium-based metalloinsertors cause necrosis in MMR-
deficient cells. This is interesting, as cancer treatment has traditionally centered on inducing 
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apoptosis, or programmed cell death, in a cancer cell. Unlike apoptosis, necrosis is cell death 
resulting from causes outside the cell, such as injury or lack of blood flow.6 
 Barton et al. further suggest necrosis as a pathway to cancer treatment, as necrosis 
releases cytokines, an agent in the inflammatory response. They argue that this inflammatory 
response would allow the immune system to then selectively target and eliminate the necrotic 
cancer cells.6 Similarly, one effective design of a metallointercalator would be one which 
selectively targets DNA mutants and causes necrosis in cancer cells. 
 The supporting ligand is an organic scaffold which typically contains nitrogen and/or 
oxygen, and coordinates to the metal center through these atoms. The ligand can be either 
bidentate, tridentate, or tetradentate, and provides stability to the metal complex, coordinating to 
sites on the metal which would otherwise be unutilized. There are many forms a supporting 
ligand can take, however the general structure is based on either a carbon-nitrogen ring or a 
series of connected pyridine rings. Supporting ligands generally occupy four of the six 
coordination sites on the metal center, and can be composed of two identical bidentate ligands or 
a single tetradentate ligand. It is also important that these ligands are neutral or monoanionic in 
order to preserve the positive overall charge of the metal complex.  
 Some classic examples of supporting ligands are bipyridine (bpy), terpyridine (terpy), 
and phenanthroline (phen), as shown in Figure 7. Many examples of metallointercalator 
complexes mentioned herein contain two bpy or phen molecules, or derivatives thereof, acting as 
supporting ligands. This method allows the supporting ligands to occupy four of the metal 
center’s coordination sites, leaving two sites available for a bidentate intercalating group. Bpy, 
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phen, and terpy, however, are unable to hydrogen bond with the DNA backbone, as they lack 
hydrogen bond donors or acceptors. Furthermore, their only two hydrogen bond acceptors, both 
nitrogen atoms, are coordinated to the metal center. The lack of ability for these supporting 
ligands to hydrogen bond with the DNA backbone will consequently have an impact on the 
stability of the metallointercalator complex when bound to DNA.  
 There are, however, supporting ligands that contain hydrogen bond donors and acceptors, 
and are thus able to hydrogen bond with the DNA backbone. There are many advantages of this, 
some of which include additional stability of the metallointercalator when bound to DNA and the 
ability to fine tune the binding of the metallointercalator to specific DNA sequences. 
 Previous work by Jacqueline Barton et al. has demonstrated the ability of the 
metallointercalator complex Λ-1-Rh(MGP)2phi5+ to be specific to the DNA sequence 5’-
CATATG-3’ (Fig. 8). The supporting group is able to hydrogen bond to the DNA backbone, 
providing the complex with increased stability. In addition, the metallointercalator bound 
competitively to the DNA sequence which is also bound by transcription factors for the gene 
following the sequence. Thus, the transcription factors were unable to bind to the DNA 
sequence, and were unable to dictate the synthesis of the protein that the gene following the 
sequence codes for.16  
Figure 7: Terpyridine (left), bipyridine (center), and phenanthroline (right), classic examples 
of supporting ligands in metallointercalators with the inability to hydrogen bond. 
 14 
 
 This gene-inhibiting property of a DNA sequence-specific metallointercalator could be 
advantageous. For example, if a sequence on a gene were damaged or mutated, a 
metallointercalator would be able to bind to the gene while the DNA sequence was repaired, 
preventing the cell from synthesizing a protein with an improper structure, which would not be 
able to carry out its necessary function. Once the DNA sequence was repaired, the 
metallointercalator would be removed from the DNA, allowing the cell to begin producing the  





protein which would now have a complete structure, rendering the protein fully functional once 
again. 
 Another metallointercalator produced by Barton et al. showed specificity for a single 
mismatch on a strand of DNA containing 2,725 base pairs.17 Mismatches are ideal targets for 
metallointercalators because they are indicators of thermodynamic instability on a strand of 
DNA, due to their poor pi-stacking ability and loss of hydrogen bonding.6 
 In addition to showing sequence specificity, some metallointercalators have shown both 
cytotoxicity and antitumor activity. For example, mer-[Ru(terpy)Cl3] (terpy = terpyridine) has 
shown cytotoxicity toward human cervix carcinoma cells in vitro (Fig. 9). In addition to 
cytotoxicity, this complex has demonstrated antitumor activity in the same cell line.18  
 Capping ligands are another option that can be used in lieu of supporting ligands. A 
capping ligand, unlike a supporting ligand, is tridentate. In binding to three of the metal’s 
coordination sites instead of four, the capping ligand allows for an open binding site on the metal 
complex, which can be modified by coordinating various ancillary groups to the metal center. 
Figure 9: Chemical structure of the cytotoxic metal complex mer-[Ru(terpy)Cl3]. This 
complex, which intercalates via the terpy ligand, demonstrates cytotoxicity and antitumor 
activity toward human cervix carcinoma cells.  
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This would further allow for modification of the metallointercalator’s binding, reactive, and 
physical properties. Terpy is a classic example of a capping ligand. Like other supporting 
ligands, however, capping ligands with the ability to hydrogen bond with the DNA backbone 
would provide more stability to the metallointercalator and increased opportunity for sequence 
specificity. 
 As previously mentioned, capping ligands allow for the utilization of ancillary groups 
which coordinate to the metal center through an open binding site. These ancillary groups can be 
modified, thereby altering the behavior of the complex in solution, when it is bound to DNA, and 
can even inhibit intercalation.8 Changing the ancillary group allows for control of the metal 
complex’s physical and chemical properties such as hydrophobicity, binding affinity, sequence 
selectivity, and cellular uptake.19 Greater control over the behavior of a metallointercalator 
translates to more efficient and more effective cancer treatments with fewer side effects. For 
example, some ancillary groups may provide the complex with a greater ability to hydrogen 
bond with the DNA backbone. Others may only interact with select DNA sequences, making 
some DNA sequences a specific target for the metallointercalator. 
Figure 10: A general diagram showing a bi-metallointercalator system where two individual 
intercalators are linked by a linking molecule. An example is shown from Thomas et al. using 
the ReI intercalator shown above.13 
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 In addition to using the open binding site of the metallointercalator for ancillary groups, 
metallointercalators can be linked to one another through their open binding sites via a linking 
molecule (Fig. 10). Jim Thomas et al. have exploited this property using ReI-dppz metal 
complexes, using the linkers 1,2-di(4-pyridyl)ethane (dpe) and 1,3-di(4-pyridyl)propane (dpp).13 
Sheldrick et al. have conducted similar studies with Ir-dppz complexes, using both  
pyrazine and 4,4’-bipyridine to link intercalators at the open binding site of the metal center.20 In 
addition, Sheldrick et al. discuss cytotoxic chlororhodiumIII complexes containing tridentate  
supporting ligands such as 1,4,7-trithiacyclononane and tris(pyrazolyl)methane (tpm).21 These 
complexes allow for the coordination of a bidentate intercalating group such as dppz, and could 
then be linked together after substitution of the chlorine for any of the aforementioned linking 
molecules.   
Previous Work 
 Previous work in the Haefner group has focused on using 1,4,7-triazacyclononane (tacn) 
as a capping ligand. Tacn is a tridentate capping ligand that allows for an open binding site on 
the metal center to which ancillary groups or linkers may bind. Unlike bpy, terpy, and 
phenanthroline, however, tacn contains three N-H groups, which have the ability to hydrogen 
bond to the DNA backbone. This hydrogen bonding ability of the capping ligand would provide 
the metallointercalator with an affinity for specific DNA sequences and more stability when 
bound to DNA.  
 The use of tacn in the Haefner group has been successful in metallointercalators 
containing a variety of metal centers, including RuII, IrIII, and RhIII. Previous examples include 
the metallointercalators [Ru(tacn)(dppz)(DMSO)]2+, [Ir(tacn)(dppz)(DMSO)]3+, 




[Rh(tacn)(dppz)(H2O)][CF3SO3]3, underwent preliminary DNA binding studies with calf-thymus 
DNA. Another DNA intercalator, ethidium bromide, was used as a fluorescence probe in the 
study. It was found that [Rh(tacn)(dppz)(H2O)]3+ replaced the ethidium bromide when it 
intercalated into DNA, resulting in the quenching of fluorescence, shown by Figure 12. This 
result indicated that [Rh(tacn)(dppz)(DMSO)]3+ had a higher binding affinity to DNA than 
ethidium briomide.  
A: 0.0 μM 
B: 2.0 μM 
C: 5.0 μM 
D: 8.0 μM 
Figure 12: Absorption spectrum of DNA binding studies of [Rh(tacn)(dppz)(H2O)]3+with calf-
thymus DNA using ethidium bromide as a fluorescence probe. Each curve corresponds to the 
fluorescence level with various concentrations of [Rh(tacn)(dppz)(H2O)]3+ ranging from 0 to 
8 μM. Emission decreases with increasing concentration of [Rh(tacn)(dppz)(H2O)]3+. 
Figure 11: Three metallointercalator complexes containing the tacn capping ligand 





 In an effort to develop new metallointercalators with different supporting groups, we 
began the examination of the tridentate ligand 4,4-dimethyl-2,2-di-2-pyridyl oxazolidine 
(Py2NO). Previously, this capping ligand has been used to prepare first-row metal complexes 
with the general formula of M(Py2NO)2n+, where M = Mn, Fe, Co, and Cu (Fig. 13).26–29 These 
complexes were found to exhibit unusual magnetic properties including spin-crossover 
intermolecular ferromagnetic exchange and single molecule magnetism.30 
 Our interest in the ligand derives from its tridentate nature. Py2NO would function as a 
capping ligand, making available the sixth coordination site of the metal center. Furthermore, the 
oxygen donor atom could act as a hydrogen bond acceptor, forming a hydrogen bond with the 
DNA backbone and thus providing more stability to the metallointercalator. Finally, the radical 
 Figure 13: Molecular structure of [Mn(Py2NO)2]2+, showing the tridentate nature of Py2NO 
and its coordination behavior to the metal center. Murray et al. suggest that the Mn2+ ion is 
in a high-spin d5 state, whereas our Re3+ ion is expected to be in a low-spin d4 state, possibly 




nature of the hydroxide group could impart additional reactivity upon intercalation of the 
complex with DNA. 
 To date, there have been no reports of using Py2NO to support second or third-row metal 
ions. We are particularly interested in using Py2NO to develop new metallointercalator 
complexes of rhenium. As previously mentioned, metallointercalators of rhenium are relatively 
unknown, with the only reported Re-dppz metallointercalator having a charge of +1. Our target is 
the metallointercalator [Re(Py2NO)(dppz)H2O]3+ (Fig. 15). This metallointercalator is novel in 
many ways, one of which is the utilization of the ReIII oxidation state instead of ReI. The Py2NO 
group will bind to the Re3+ ion through its two nitrogen atoms on the molecule’s pyridine rings, 
as well as through a free radical oxygen which is part of a nitroxide on the oxazolidine ring. The 
dppz group will bind to the Re3+ ion through two of its nitrogen atoms. Figure 14 shows the open 
binding site, designated by “L”, to which ancillary groups may bind. 
 This metallointercalator design has the potential to show various interesting properties. 
One such property, for example, is the ability to be tuned to bind to specific DNA sequences. 
Due to the complex’s open binding site, this metallointercalator’s physical and chemical 
properties will change, depending on the substituent bound to the open binding site of the 
complex. For example, some substituents may allow for increased hydrogen bonding between 
the metallointercalator complex and the DNA, thus allowing for more stability of the interaction 
Figure 14: A diagram of one of our proposed metallointercalators. Emphasis is placed on the 
open binding site, designated by the bolded “L”, which allows for the fine-tuning of the 
physical and chemical properties of the complex. 
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between the metallointercalator and the DNA. Conversely, another substituent may inhibit 
hydrogen bonding between the metal complex and the DNA at that or another specific site. 
 Another property that we expect this metallointercalator complex to exhibit is the ability 
to emit light when bound to DNA. As mentioned previously, some metallointercalator complexes 
containing dppz have been shown to fluoresce when bound to DNA, behaving as a “light 
switch”. This property would facilitate the process of identifying DNA damage, reducing the 
time required for the DNA damage to be repaired. 
 Herein, we describe the synthesis and characterization of the metallointercalator 
intermediate Re(Py2NO)Cl3. We have also discovered another intermediate, ReO(dpk-OEt)Cl2, a 
known complex which has been synthesized through a novel method in higher yield. A 
compound believed to be the metallointercalator [ReO(dpk-OEt)dppz]2+ has been synthesized as 
well. The syntheses of these compounds, their physical and chemical properties, as well as data 




 Materials and Methods. All reagents and solvents were purchased from commercial 
sources and used without further purification. Unless otherwise noted, all reactions were 
Figure 15: Chemical structure of one of our proposed novel metallointercalators: 
[Re(Py2NO)(H2O)dppz]3+. A shorthand for Py2NO is shown to the right of the structure. 
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conducted in an argon atmosphere using standard Schlenk line techniques. Work up of products 
was performed in air. 
 Characterization Techniques. Powders and crystals were analyzed by IR spectroscopy 
using a PerkinElmer® Frontier FT-IR/NIR Spectrometer. UV/Vis analysis was conducted using 
both a PerkinElmer® Lambda 25 UV/Vis Spectrometer and a Hewlett-Packard® Model 8453 
diode array spectrometer in the solvents specified by the synthetic procedure. NMR spectral data 
was obtained using a JEOL 400 mHz spectrometer in deuterated solvents specified by the 
synthetic procedure. Chemical shifts were referenced using the known chemical shifts of the 
protio impurity in the deuterated solvent. X-ray diffraction studies were conducted by Dr. James 
Golen at the University of Massachusetts, Dartmouth. Data were collected at 24 oC on a Bruker 
D8 Venture X-ray instrument using Mo K alpha radiation and data were corrected for absorption 
with SADABS. Structure was solved by direct methods and all non-hydrogen atoms of main 
molecule were refined anisotropically by full matrix least squares on F2. All hydrogen atoms 
were placed in calculated positions with appropriate riding parameters. 
 Synthetic Procedures.  
 4,4-dimethyl-2.2-di(2-pyridyl)oxazolidine (Py2NO). Synthesis of Py2NO was adapted 
from a literature procedure.26 Di(2-pyridyl)ketone (9.71 g, 51.7 mmol), 2-amino-2-
methylpropanol (110 mL, 1.13 mol), and concentrated sulfuric acid (25 drops) were added to 200 
mL of toluene and refluxed for four days. The solution was then cooled to room temperature and 
concentrated. Water (200 mL) and diethyl ether (100 mL) were then added to the solution, 
forming aqueous and organic layers. The organic layer was separated, and the aqueous layer was 
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extracted twice with CH2Cl2 (100 mL). The organic layers were combined and dried with 
MgSO4, and the solvents were evaporated, yielding an intermediate compound.26  
 The intermediate (3.01 g, 11.8 mmol) was mixed with diethyl ether (40 mL), and the 
solution was cooled on ice. Added to this solution was a solution containing meta-
chloroperoxybenzoic acid (MCPBA, 4.34 g, 17.6 mmol) in 40 mL of diethyl ether. The reaction  
mixture was allowed to stand for four hours. A cold, 5% Na2CO3 solution (40 mL) was added to 
the reaction mixture to separate the aqueous and organic layers. The organic phase was extracted 
four times with the Na2CO3 solution (40 mL), while the aqueous phase was extracted five times 
with CH2Cl2 (40 mL). The organic phases were combined, washed twice with cold 5% Na2CO3 
solution (40 mL), and dried with MgSO4. The solvents were evaporated under vacuum, yielding 
an orange solid.26 The orange solid was chromatographed on silica gel with acetone. Yield: 2.20 
g (68%). IR (cm-1): 3055 w, 2975 w, 2873 w, 1682 m, 1586 s, 1571 m, 1541 m, 1464 s, 1435 s, 
1363 m, 1318 m, 1245 m, 1051 s, 992 s, 944 s, 775 s, 751 s. UV/Visible (CH3CN; λmax, nm): 
260. 
 Tetrabutylammonium Octachlorodirhenate (TBA2[Re2Cl8]). Synthesis of 
TBA2[Re2Cl8] was adapted from a literature procedure.31 TBA[ReO4] (1.5 g, 3.04 mmol) was 
added to a 100 mL Schlenk flask, and the flask was filled with argon. Benzoyl chloride (15 mL, 
129 mmol) was then syringed into the flask, resulting in a pale yellow solution, which changed in 
color from pale yellow to orange, red, and eventually dark green as the solution was heated. The 
flask was fitted with a reflux condenser and the solution was gently refluxed overnight (20-24 h). 
After 24 h, the reaction was cooled to room temperature, and a solution containing 
tetrabutylammonium bromide (2.5 g, 7.75 mmol), ethanol (35 mL), and concentrated aqueous 
hydrochloric acid (5 mL) was added to the reaction mixture. This solution was allowed to reflux 
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for an additional hour, after which it was cooled to room temperature and evaporated to roughly 
25-30 mL using a rotary evaporator. The solution was then filtered through a 30 mL medium 
porosity sintered glass frit, and the resulting blue crystals were washed with 3 5-mL portions of 
ethanol, 10 mL of diethyl ether, and dried under vacuum.  
 The crude product was added to stirred, boiling methanol (50 mL) containing one drop of 
concentrated aqueous hydrochloric acid, then immediately filtered through a 30 mL medium 
porosity sintered glass frit into concentrated aqueous hydrochloric acid (50 mL). Some dark blue 
crystals precipitate at this stage and were isolated. Evaporation of the methanol via a rotary 
evaporator yields more crystals. Yield: 1.32 g (76%). IR (cm-1): 2954 s, 2876 s, 1476 s, 1381 s, 
1179 w, 1152 m, 1107 w, 1051 w, 1025 m, 879 s, 796 w, 736 s. UV/Visible (CH3CN; λmax, nm): 
685. 
 Re(Py2NO)Cl3. TBA2[Re2Cl8] (100 mg, .088 mmol) and Py2NO (47.4 mg, 0.175 mmol) 
were refluxed in CH3CN (5 mL) in air for 24 hours. The acetonitrile was removed under vacuum, 
leaving a brown, oily product to which 10 mL each of acetone and hexane were added (1:1 
volumetric ratio). The solvents were removed using a rotary evaporator, resulting in the 
formation of a red/brown solid which was washed with ethanol and filtered using a Hirsch 
funnel. IR (cm-1): 3082 w, 2963 w, 2871 w, 1604 m,  1653 m, 1441 s, 1283 m, 1236 m, 1164 m, 
1093 m, 1028 m, 965 m, 912 m, 766 s. UV/Visible (CH3CN; λmax, nm): 485, 272. 1H NMR (400 
MHz, CD3CN, δ): 8.75 (t, 1H, py), 8.2 (q, 2H, py), 7.6 (d, 1H, py), 3.05 (s, 2H, -CH2), 0.95 (s, 
6H, (-CH3)2). 
 ReO(dpk-OEt)Cl2 (Method A). TBA2[Re2Cl8] (100 mg, 0.088 mmol) and Py2NO (47.4 
mg, 0.175 mmol) were refluxed in ethanol (10 mL) under argon for 24 hours. The solution 
turned green upon addition of the ethanol, and became very dark within 15 minutes. A blue 
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precipitate formed after 24 hours, and was filtered using a Hirsch funnel and washed with diethyl 
ether. The solid was dissolved in methylene chloride, and the solvent was allowed to slowly 
evaporate. Dark blue crystals formed upon evaporation of the methylene chloride. Yield: 30 mg 
(34%). Infrared, UV-visible, and NMR spectroscopic data of the sample were also obtained. IR 
(cm-1): 3073 w, 2978 w, 1601 m, 1438 m, 1280 m, 1233 s, 1218 m, 1170 m, 1120 w, 1093 m, 
1045 m, 1007 m, 965 s, 953 m, 891 w, 805 m, 766 s, 698 s, 671 s. UV/Visible (CH3CN; λmax, 
nm): 342, 315, 249. 1H NMR (400 MHz, (CD3)2SO, δ): 8.42 (d, 2H, py), 8.05 (q, 4H, py), 7.78 
(t, 2H, py), 3.65 (q, 2H, -OCH2CH3), 1.30 (t, 3H, -OCH2CH3). 
 ReO(dpk-OEt)Cl2 (Method B). TBA2[Re2Cl8] (250 mg, 0.219 mmol) and di-2-pyridyl 
ketone (80.7 mg, 0.438 mmol) were refluxed in ethanol (10 mL) in air. The reaction proceeded 
as previously described, with the solution turning light green upon addition of ethanol and darker 
green within 15 minutes. A blue precipitate formed after 24 hours of reflux, and was filtered 
through a Hirsch funnel and washed with ethanol and diethyl ether. The crude product was 
dissolved in methylene chloride and filtered through a 5.75” inch glass pipet filter containing 
roughly 0.5 cm of Celite® into a 20 mL scintillation vial. The vial was then covered with 
Parafilm pierced with seven evenly distributed holes, and the solvent was allowed to slowly 
evaporate. Blue crystals formed upon evaporation of the solvent. Yield: 178 mg (81%).  
 [ReO(dpk-OEt)dppz]2+. ReO(dpk-OEt)Cl2 (50 mg, 0.995 mmol), silver 
trifluoromethanesulfonate (50.9 mg, 0.198 mmol), and dppz (28.6 mg, 0.101 mmol) were added 
to CH3CN (5 mL) in a 50 mL round-bottomed flask. The solution was then gently refluxed in air 
for 24-28 hours. A gray/green precipitate formed and was filtered off using a Hirsch funnel. The 
resulting dark red filtrate was then pipet filtered through roughly 0.5 cm of Celite®. The solution 
was cooled on ice, and saturated aqueous potassium hexafluorophosphate was subsequently 
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added. The solution then appeared as a brown suspension as [ReO(dpk-OEt)dppz][PF6]2 
precipitated. The red/brown precipitate was then isolated by filtration through a medium porosity 
sintered glass frit before being dried under vacuum. The compound believed to be [ReO(dpk-
OEt)dppz][PF6]2 was then dissolved in acetone and the solution was pipet filtered through 0.5 cm 
of Celite®. In a 20 mL scintillation vial, 5 mL of this solution was layered with toluene (5 mL), 
and the acetone was allowed to evaporate. Small, cube-shaped, red-orange crystals formed. 
Yield: 83.7 mg (42%). IR (cm-1): 3642 w, 3099 w, 1700 w, 1608 m, 1497 m, 1423 m, 1360 m, 
1238 m, 1080 m, 1038 m, 957 m, 829 s, 763 s, 728 s. UV/Visible (CH3CN; λmax, nm): 374, 358, 
277. 1H NMR (400 MHz, CD3CN, δ): 9.70 (d, 1H, py), 8.50 (q, 2H, dppz), 8.17 (q, 1H, py), 7.97 
(d, 1H, dppz), 7.83 (t, 1H, py), 0.95 (t, 1H, -OCH2CH3). 
 
Results and Discussion 
Synthesis of Py2NO 
  
 The Py2NO ligand was synthesized first by the reflux of di-2-pyridyl ketone, 2-amino-2-
methyl propanol, and sulfuric acid in toluene (Fig. 16). The solution was a bronze color upon 
addition of the reagents. Upon quenching of the reaction, the solution appeared to be two layers, 
with a gold colored top layer and a smaller, cloudy layer on the bottom which contained some 
precipitate. The organic product was isolated from the aqueous byproduct, and this solution was 
Figure 16: Chemical reaction of di-2-pyridyl ketone, 2-amino-2-methyl propanol, and 
MCPBA to produce the tridentate ligand Py2NO. 
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light amber in color. A crude, solid product was later obtained, and was light yellow in color 
with a chalky texture. 
 This crude product was then oxidized with 3-chloroperoxybenzoic acid (MCPBA) to 
produce the nitroxide product. The reaction mixture changed in color from green to yellow and 
eventually orange. The crude product was then chromatographed on silica gel with acetone, 
yielding the pure Py2NO ligand. 
Synthesis of Re(Py2NO)Cl3 
 Our initial objective was to react two equivalents of Py2NO with the Re3+ precursor 
[TBA]2[Re2Cl8] in an effort to prepare the intermediate Re(Py2NO)Cl3 (Fig. 17). We then 
envisioned that removal of the halides followed by addition of dppz would lead to the new 
rhenium-based metallointercalator [Re(Py2NO)(dppz)L]3+ (L = CH3CN or H2O). Reaction of 
Py2NO with [TBA]2[Re2Cl8] under reflux with CH3CN in air produced a dark red/brown 
solution. Similar results were obtained under reflux conditions, as well as in other aprotic 
solvents such as acetone. Removal of the solvent under vacuum consistently produced an oily, 
intractable solid. We found that a red/brown precipitate could be obtained by the slow addition of 
equal volume of hexane to acetone solutions of the product, which were then evaporated under 
vacuum. The crude, red/brown solid compound was soluble in polar aprotic solvents, specifically 
acetone, acetonitrile, and methylene chloride. 
 An IR spectrum of the crude solid exhibited vibrations similar to that of free Py2NO but 
shifted from 0 to 30 cm-1, strongly suggesting coordination of the ligand to the rhenium metal 
center. The electronic absorption spectrum of the solid contained absorbances at 485 and 272 
nm. The Re2Cl82- δ-δ* transition at 685 nm, however, was absent, indicating that cleavage of the 




  The 1H NMR spectrum of the solid (Fig. 18) revealed a complex set of broad resonances 
in the aromatic region. The broadness of the resonances is indicative of a paramagnetic species. 
Cleavage of the Re-Re quadruple bond would produce a mononuclear Re3+, low spin d4 center 
that would be expected to be paramagnetic. It appears as though there are two sets of aromatic 
resonances. The first set consists of broad resonances at 8.75, 8.2, and 7.6 ppm. This would be 
consistent with a symmetric Re(Py2NO) species such as Re(Py2NO)Cl3, where the two pyridyl 
groups would be equivalent. There is also a more intense resonance at 1.0 ppm which integrates 
for roughly seven protons. This resonance corresponds to the dimethyl group on the oxazolidine 
ring. The methylene protons of the ring appear at 3.0 ppm. The second set of resonances in the 
aromatic region are more numerous and suggest a Py2NO complex that lacks mirror symmetry, 
thus making the pyridyl rings inequivalent. Similar resonances appear upfield in the methyl and 
methylene regions.  




















































































































































































































































































 Unfortunately, attempts to obtain single crystals of the intermediate Re(Py2NO)Cl3 have 
been unsuccessful, and further studies will need to be conducted in order to properly characterize 
this complex as Re(Py2NO)Cl3. The yields of this product were very low, and were insufficient 
for the synthesis of the metallointercalator [Re(Py2NO)(dppz)H2O]3+. It is important to note that 
since the complex is expected to be paramagnetic, the exact oxidation state of the metal will be  
complicated by the presence of the nitroxide radical of Py2NO. Regardless of the metal oxidation 
state, however, that the overall charge of the complex should remain 3+.  
Synthesis of ReO(dpk-OEt)Cl2 
 Surprisingly, the reaction between TBA2[Re2Cl8] and Py2NO in alcohols such as ethanol 
under argon resulted in the precipitation of a blue solid (Fig. 19). Single crystals of this blue 
complex were obtained by dissolution in and slow evaporation of methylene chloride. An x-ray  
 
diffraction study on the compound revealed it to be the ReV oxo complex ReO(dpk-OEt)Cl2. 
Apparently, this reaction results in the decomposition of the Py2NO ligand to reform di-2-pyridyl 
ketone, which then reacts with ethanol to form the dpk-OEt ligand. While the origin of the ReV 
oxo is unknown, it appears likely to be derived from the nitroxide oxygen of the Py2NO. Transfer 
of the oxygen to the rhenium metal center facilitates further decomposition of Py2NO. Additional  
 





studies are required to identify the source of the oxo group and the decomposition byproducts of 
the Py2NO ligand. 
 This ReV oxo sample can be prepared in much higher yield through the direct reaction of 
TBA2[Re2Cl8] with di-2-pyridyl ketone in ethanol in air (Fig. 20). In fact, the yield for ReO(dpk-
OEt)Cl2 using TBA2[Re2Cl8] is higher than that previously reported by Gonzàlez et al. using 
TBA[ReCl5(DMF)] as a precursor.32 A proposed mechanism of this reaction is shown by Figure 
21, which suggests that coordination of the nitrogen atoms to the metal activates the carbonyl 
carbon of di-2-pyridyl ketone. Ethanol acts as a nucleophile, attacking the carbonyl carbon which 
then produces the dpk-OEt ligand. 
Figure 20: Chemical reaction of TBA2[Re2Cl8] and di-2-pyridyl ketone in ethanol to produce 
the intermediate ReO(dpk-OEt)Cl2. 
Figure 21: Proposed mechanism of the formation of the dpk-OEt. Metal coordination 
activates the carbonyl carbon of the di-2-pyridyl ketone, causing the reversible addition of 



















































































































































































































































 The electronic absorption spectrum of ReO(dpk-OEt)Cl2 showed absorbances at 342, 
315,  and 249 nm, which indicates both the cleavage of the Re-Re quadruple bond as the δ-δ*  
transition at 685 nm is absent, and the coordination of the dpk-OEt ligand to the rhenium metal 
center. The IR spectrum exhibits absorptions consistent with the coordination of the dpk-OEt 
ligand to the rhenium center. In addition, the strong absorbance at 965 cm-1 corresponds to the 
Re=O stretch, also reported at 965 cm-1 by Gonzàlez et al.32 The 1H NMR spectrum (Fig. 22) 
shows three major resonances in the aromatic region between 7.5 and 8.5 ppm, which would be 
consistent with the expectation of ReO(dpk-OEt)Cl2 being a symmetric species. The quartet at 
8.0 ppm is suggestive of proton coupling occurring within the pyridine rings, which would be 
confirmed by future 2-D NMR experiments such as COSY and HMQC. The upfield resonances 
at 3.65 ppm and 1.30 ppm correspond to the CH2 and CH3 protons on the ethoxyl group, 
respectively. The diamagnetic nature of this low spin d2 center suggests the two d-electrons 
occupy the same molecular orbital, highlighting the labile nature of the ReO(dpk-OEt)Cl2 
complex. The x-ray structure, 
 
Figure 23: X-ray crystal structure showing ReO(dpk-OEt)Cl2. Rhenium, Oxygen, Chlorine, 
Nitrogen, Carbon, Hydrogen (White). (Gonzàlez, et al. 2011).  
Re-O: 1.98 Å 




shown in Figure 23, shows ReO(dpk-OEt)Cl2 to be a distorted octahedron, as the bond angle 
between the oxo, rhenium center, and singly-bonded oxygen is 156.7°.32 The Re-oxo bond length 
is 1.69 Å, indicative of a strong π interaction. The Re-O bond length of 1.98 Å is consistent with 
a Re-O singly-bonded oxygen. 
 This complex is both similar and different to Re(Py2NO)Cl3 as a metallointercalator 
intermediate. Like Re(Py2NO)Cl3, the supporting group of ReO(dpk-OEt)Cl2 is tridentate, 
binding to three of the six open binding sites on the rhenium metal. This shared nature of the 
binding of the supporting group makes ReO(dpk-OEt)Cl2 a viable candidate for a 
metallointercalator.  
 Conversely, ReO(dpk-OEt)Cl2 is different in that it is an oxo complex: a metal complex 
in which a single oxygen atom forms a double-bond with a metal. This complex differs from the 
originally proposed [Re(Py2NO)(H2O)dppz]3+ in that the H2O molecule can be more easily 
substituted with other substituent groups than the oxygen atom. This will likely affect the range 
of DNA binding behaviors that [ReO(dpk-OEt)dppz]2+ will possess, since the oxygen atom has a  
high binding affinity to the rhenium metal, and thus will be more difficult to substitute with other 
groups in order to alter the DNA binding behavior of the complex. This does not, however, 
render [ReO(dpk-OEt)dppz]2+ useless as a metallointercalator. The doubly-bonded oxygen atom 
will be able to exhibit hydrogen bonding with base pairs in the major and minor grooves of 
DNA. There have also been no reports of a metallointercalator complex containing an oxo, 






Synthesis of [ReO(dpk-OEt)dppz]2+ 
 ReO(dpk-OEt)Cl2 was then refluxed with Ag+ and dppz in acetonitrile in an attempt to 
synthesize the metallointercalator [ReO(dpk-OEt)dppz]2+ (Fig. 24). After the AgCl precipitate 
was filtered off, addition of saturated aqueous KPF6 solution to the reaction filtrate yielded a 
red/brown solid. An IR spectrum of the crude product shows similarities between the vibrations 
of the ReO(dpk-OEt)Cl2 intermediate and the product believed to be [ReO(dpk-OEt)dppz][PF6]2. 
Major vibrations shifted by 50 cm-1 or less between the two spectra, suggesting that the dpk-OEt  
 
ligand remained intact and that dppz is coordinated to the two open binding sites previously 
occupied by the halide atoms. In addition, a vibration at 829 cm-1 is present, which corresponds 
to the PF6- counterion. This value is shifted roughly 20 cm-1 from the P-F stretch corresponding 
to a sample of KPF6, strongly suggesting that PF6- is present in the sample as an anion. 
Electronic absorption data shows peaks which are similar in structure between the ReO(dpk-
OEt)Cl2 and [ReO(dpk-OEt)dppz]2+ samples (342, 315, and 249 nm and 374, 358, and 277 nm, 
respectively). These absorptions are shifted 30-40 nm between the samples, which is a promising 
suggestion that dppz is coordinated to the rhenium metal center.  
 A 1H NMR spectrum of the sample shows five resonances in the aromatic region (Fig. 
26). Three of these aromatic resonances appear to be triplets and quartets, suggesting hydrogen 
coupling on the dpk-OEt ligand and dppz. This will be determined through future 2-D NMR 
Figure 24: Chemical reaction of ReO(dpk-OEt)Cl2, silver trifluoromethanesulfonate, and 
dppz in acetonitrile to produce the metallointercalator [ReO(dpk-OEt)dppz]2+. 
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experiments, specifically COSY and HMQC. The ReO(dpk-OEt)Cl2 resonances in the aromatic 
region appear to be shifted, which suggests the coordination of dppz to the rhenium metal center, 
and thus the synthesis of the metallointercalator complex [ReO(dpk-OEt)dppz]2+. The upfield 
region consists of a triplet at 0.95 ppm, corresponding to the CH3 protons on the ethoxyl group of 
dpk-OEt, and a small resonance at 3.05 ppm which is likely a quartet associated with the CH2 
protons of the ethoxyl group. These signals are less pronounced than the ethoxyl group signals in 
Figure 23, which suggests that this group may have the ability to reversibly add to and leave the 
carbonyl carbon, forming free ethanol.  
 The reversible nature of the interaction of di-2-pyridyl ketone and ethanol can be seen in 
the isolation of a di-rhenium byproduct from the reaction of ReO(dpk-OEt)Cl2 with silver and 
dppz. A preliminary crystal structure of this byproduct (Fig. 25) reveals an edge-sharing 
bioctahedral structure where two ReIII centers are bridged by a chloride and an oxo group. One of 
the rhenium centers is coordinated by a tridentate dpk-OEt group, while the second rhenium 
center is supported by a bidentate di-2-pyridyl ketone ligand. The two rhenium centers are 
separated by 2.494 Å 
Figure 25: X-ray crystal structure of a di-rhenium byproduct. The byproduct is a ReIII-ReIII 
dimer with a bridging oxygen and a bridging chloride, shown in red and green, respectively. 
Dpk is shown as a ligand on one of the rhenium centers, while dpk-OEt is shown as a ligand 


































































































































































































































































































































 We are continuing to work toward obtaining Re(Py2NO)Cl3 as a crystalline product, after 
having discovered a synthesis method which yields a solid product. We have also synthesized the 
metallointercalator intermediate ReO(dpk-OEt)Cl2 through a novel synthesis method which 
produced higher yields than the literature had reported. This complex was then reacted with Ag+ 
and dppz in an attempt to produce the metallointercalator [ReO(dpk-OEt)dppz]2+. A solid 
product precipitated as a PF6- salt, which is believed to be the desired metallointercalator. All 
products have been characterized by IR, NMR, and UV/Vis spectroscopy, and x-ray diffraction 
studies have been conducted on single crystal samples. Attempts to obtain the metallointercalator 
[ReO(dpk-OEt)dppz]2+ are ongoing. 
 Future work will consist of obtaining crystals of both Re(Py2NO)Cl3 and [ReO(dpk-
OEt)dppz]2+ for X-ray diffraction studies. Further syntheses will also attempt to increase the 
yield of Re(Py2NO)Cl3. Upon X-ray diffraction studies of Re(Py2NO)Cl3, further syntheses will 
attempt to produce the metallointercalator [Re(Py2NO)(H2O)dppz]3+ using dppz and Ag+ salts. 
Upon X-ray diffraction studies of [ReO(dpk-OEt)dppz]2+, DNA binding studies will be 
commenced in collaboration with Dr. Thayaparan Paramanathan of the Department of Physics at 
Bridgewater State University in order to achieve the ultimate goal of this project: to understand 
how these metallointercalators interact with DNA, and to determine their viability as DNA 
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